Kristen M. O’Dwyer

Author

Kristen M. O’Dwyer

University of Rochester Medical Center ORCID

Also Known As

K.M. O’Dwyer, Kristen M O'Dwyer, Kristen M. O'Dwyer, Kristen M. O’Dwyer, Kristen Marie O'Dwyer, Kristen Marie O’Dwyer, Kristen O'Dwyer, Kristen Odwyer, Kristen O’Dwyer, Kristen M. O’Dwyer

114

Publications

Citations

H-Index

Concepts

All Affiliations

University of Rochester Medical Center Dana-Farber Cancer Institute University of Rochester Fred Hutch Cancer Center Memorial Sloan Kettering Cancer Center

About

Kristen M. O’Dwyer is an author at University of Rochester Medical Center specializing in medicine, cancer research, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2.2K
2	Health Sciences	4	4	2.2K
3	Natural Sciences	1	1	39
4	Biochemistry	1	1	39
5	Cell Biology	1	1	1.3K

Kristen M. O’Dwyer

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells Eleni D. Lagadinou, Alexander Sach, Kevin P. Callahan, Cell stem cell Hematological MalignancyCancer ResearchMedicineMixed-phenotype Acute LeukemiaCell Death	2013	1.3K
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, The Lancet Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology	2021	721
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression Tzu‐Chieh Ho, Mark W. LaMere, Brett M. Stevens, Blood	2016	232
Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells Shanshan Pei, Mohammad Minhajuddin, Kevin P. Callahan, Journal of Biological Chemistry	2013	196
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole, Blood	2021	190
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults Mikkael A. Sekeres, Gordon Guyatt, Gregory A. Abel, Blood Advances	2020	176
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia Claire Roddie, Karamjeet Sandhu, Eleni Tholouli, New England Journal of Medicine	2024	145
Discovery of Potent Parthenolide-Based Antileukemic Agents Enabled by Late-Stage P450-Mediated C—H Functionalization Joshua N. Kolev, Kristen M. O’Dwyer, Craig T. Jordan, ACS Chemical Biology	2013	112
Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study Kah Poh Loh, Erika Ramsdale, Eva Culakova, JMIR Cancer	2018	76
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, Journal of Hematology & Oncology	2022	73

Page 1